The patient has a combined primary immunodeficiency with low levels of CD3, CD4 and CD19, and contrary to what we expected, his history of infections between 2017 and 2022 showed a controlled number of infections which were common to patients with CIVD. This evidence concerns the gene CD19 and infection.